Literature DB >> 2785261

Problems in determining the etiology of community-acquired childhood pneumonia.

D Isaacs1.   

Abstract

Fifty-seven children ages 1 month to 12 years hospitalized because of community-acquired pneumonia were compared with age-matched controls who had acute asthma without pneumonia to test the value of rapid bacterial antigen detection and clinical and radiographic criteria for diagnosis of bacterial pneumonia. Bacterial pneumonia, defined on the basis of positive cultures of blood or pleural fluid, was diagnosed in 4 children (7%), 1 of whom also had viral pneumonia. Viral pneumonia, defined as a positive nasopharyngeal sample or positive serology, was diagnosed in 20 children (35%). Serum and concentrated urine were tested by latex agglutination (Wellcogen) for Haemophilus influenzae type b and pneumococcal antigens and by countercurrent immunoelectrophoresis for pneumococcal antigens. Pneumococcal antigen could not be detected in serum or urine from 3 children with culture-proved pneumococcal pneumonia, indicating poor sensitivity of the tests. In contrast apparent H. influenzae type b antigenuria was detected by latex agglutination in 4 of 40 children with pneumonia but also in 5 of 57 controls, and a sensitive enzyme-linked immunosorbent assay for polyribosyl ribitol (PRP) phosphate antigen showed that all 9 cases were false positives. The specificity of H. influenzae type b antigen detection was thus poor. Children with viral and bacterial pneumonia could not be distinguished by radiographic or clinical criteria (symptoms, fever) or by total or differential white blood cell counts, serum C-reactive protein or nasal or serum interferon levels. It is not possible to distinguish reliably childhood viral from bacterial pneumonia clinically or by rapid diagnostic tests.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785261

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  23 in total

1.  British Thoracic Society Guidelines for the Management of Community Acquired Pneumonia in Childhood.

Authors: 
Journal:  Thorax       Date:  2002-05       Impact factor: 9.139

2.  Rationalised prescribing for community acquired pneumonia: a closed loop audit.

Authors:  H Clements; T Stephenson; V Gabriel; T Harrison; M Millar; A Smyth; W Tong; C J Linton
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

3.  Etiology and response to antibiotic therapy of community-acquired pneumonia in French children.

Authors:  D Gendrel; J Raymond; F Moulin; J L Iniguez; S Ravilly; F Habib; P Lebon; G Kalifa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-05       Impact factor: 3.267

Review 4.  Clinical use of cefuroxime in paediatric community-acquired pneumonia.

Authors:  C Olivier
Journal:  Paediatr Drugs       Date:  2000 Sep-Oct       Impact factor: 3.022

5.  Pneumonia in childhood: etiology and response to antimicrobial therapy.

Authors:  O Ruuskanen; H Nohynek; T Ziegler; R Capeding; H Rikalainen; P Huovinen; M Leinonen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-03       Impact factor: 3.267

6.  The Impact of Prior Antibiotic Therapy on Outcomes in Children Hospitalized for Community-Acquired Pneumonia.

Authors:  Eran Lavi; Oded Breuer
Journal:  Curr Infect Dis Rep       Date:  2016-01       Impact factor: 3.725

7.  Community acquired pneumonia--a prospective UK study.

Authors:  P Drummond; J Clark; J Wheeler; A Galloway; R Freeman; A Cant
Journal:  Arch Dis Child       Date:  2000-11       Impact factor: 3.791

8.  Comparison of two antibiotic regimens in the empirical treatment of severe childhood pneumonia.

Authors:  Feyzullah Cetinkaya; Abdulkadir Gogremis; Gunsel Kutluk
Journal:  Indian J Pediatr       Date:  2004-11       Impact factor: 1.967

9.  Evaluation of a new tube latex agglutination test for detection of type-specific pneumococcal antigens in urine.

Authors:  M Rosario; Z Capeding; H Nohynek; P Ruutu; M Leinonen
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

10.  Bacteraemia and antibiotic use in respiratory syncytial virus infections.

Authors:  P Bloomfield; D Dalton; A Karleka; A Kesson; G Duncan; D Isaacs
Journal:  Arch Dis Child       Date:  2004-04       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.